专利摘要:
Novel corticoids of formula I <IMAGE> (I), wherein X is beta -hydroxymethylene, beta -fluoromethylene or carbonyl; Y is fluorine, chlorine, hydroxy, or acyloxy of 1-10 carbon atoms; and R1 is acyloxy of 1-10 carbon atoms, possess strong anti-inflammatory activity when administered topically and display only minor systemic side effects.
公开号:SU730311A3
申请号:SU772529649
申请日:1977-10-04
公开日:1980-04-25
发明作者:Аннен Клаус;Лаурент Генри;Хофмайстер Хельмут;Вихерт Рудольф;Вендт Ханс;Фридрих Капп Иоахим
申请人:Шеринг Аг (Фирма);
IPC主号:
专利说明:

10 ml of methanesulfonic acid chloride was added dropwise and the mixture was stirred for 1 hour. After drying with ice water and extraction with methylene chloride, the organic phase was washed with water, dried over Na, 8O + and evaporated in vacuo. The yield of crude product 5,89 g. The resulting product is purified by chromatography on 580 tons of silica gel, washed by gradient elution with a mixture of methylene chloride / acetone (0-10% acetone). Yield 17 (-acetoxy-9cX-chloro-11 p-hydroxy-21-mesyloxy-1, 4-pregnadien-3, 20-dione, 2.8 g, mp. 213 ° C.
B. 2 -G 17 (; -acetoxy-9 (I-chloro-11-oxy-21-mesyloxy-1, 4-pregnadien-3, 20-dione is stirred for 4.5 hours at a bath temperature with 12 g of lithium chloride in 80 ml of hexamethylphosphoric triamide.After precipitating with a solution of sodium chloride in ice water, the mixture is filtered, the residue is washed with water, dissolved in chloride, methylene, and washed again. Dried over sodium sulfate and evaporated in vacuo. The crude product is subjected to chromatographic purification on 150 g of silica gel, washed gradiently by elution with a mixture of hexane / ethyl acetate (0-50% latsetata). Yield. atsetosi-21-chloro-11 (oxy-1, 4,8-pregnatrien-3, 20-dione, 400 mg, mp. 207 ° C.
Example 2.A. 5 g of crude 9c) -chloro-11 p-21-dioxy. -17 ° C-propionyloxy-1,4-pregnadien-3, 20-dione are stirred overnight at room temperature with 6 g of tosyl chloride in 50 ml of pyridine. After precipitation with ice water, it is extracted with methylene chloride, the extract is washed with water and evaporated in vacuum after drying over sodium sulfate. Crude product yield 6.4 g. The crude product is subjected to chromatographic purification of 640 g of kieselgel, washing out and gradient elution with a mixture of methylene chloride / acetone (0-15% acetone). The yield of 9-chloro-1 l-oxy-7c) l-propionic-21-rosyl-1, 4-β-prenadiene-3,20-dione 4.2 g, so pl. 165-1670С.
B. 2 g of 9c-chloro-11p-oxy-17L-propionyloxy-21-tosyl-xy-1, 4-pregnadiech-3, 20-dione in 40 ml of hexamethylphosphoric triamide is stirred for 6 hours at a bath temperature of 85 ° e. lithium chloride. After precipitation with ice water, the mixture is filtered, the residue is washed with water, then dissolved in methylene chloride. The organic solution is dried over sodium sulfate and evaporated in vacuo. Crude yield: 1.4 g. Crude product is purified by chromatography on 140 g of silica gel, washed by gradient elution with a mixture of hexane / ethyl acetate (0-50% ethyl acetate
Yield: 21-chloro-11 p-hydroxy-1 7 "t-propionyloxy-1, 4,8-pregnatriene-3, 20-dione 500 mg.
Example 3
A. 7 g of crude 17c-benoyoyloxy-9l-chloro-1ip, 21-dioxyl-1,4-pregnadien-3, 20-dione in 70 ml of pyridine is reacted with 8 g of tosyl chloride. Crude yield 8.9 g. The crude product is purified by chromatography on 900 g of silica gel, washed by gradient elution with a mixture of methylene chloride / acetone (0-15% acetone). Yield 17c / o-benzoyl-6-oxy-9c1.-chloro-11-oxy-21-tosyloxy-1, 4-pregnadiene-3, 20-dione 5.1 g.
B. 4 g of the specified tosylate as in example 2B is treated with lithium chloride. Crude yield: 3.1 g. Crude product is purified by chromatography on 350 g of 0 silica gel, washed by gradient elution with a mixture of hexane / ethyl acetate (0-50% ethyl acetate). The yield is 176-benzoyloxy-21-chloro-11p) -oxy-1, 4, 8-pregnatriene-3, 20-dione 2.4 g, m.p. (decomposition).
Example 4 To a cooled mixture of 6.11 ml of pyridine and 67.5 ml of methylene chloride, 3.34 g of chromium trioxide was added in portions. Stir for 15 minutes at room temperature and cool again to 0 ° C. To this solution was added dropwise 2.6 g of crude 17 ° C-benzoyloxy-21-chloro-11r-hydroxy-1, 4.8-pregnaterien-3, 20-dione in 56 ml of methylene chloride and stirred, followed by 3, 5 h at room temperature. Then the mixture is filtered, the residue is repeatedly treated with methylene chloride and the combined organic phases are washed with water. After drying over sodium sulfate, evaporated in vacuo. Crude product yield 3.9 g. The crude product is subjected to chromatographic purification on 300 g of silica gel, washed by gradient elution with a mixture of methylene chloride / acetone (0-10% acetone). Yield 17 ° C-benzoyloxy-21-chloro-1, 4,8-pregnatriene-3, 11.2 O-trioya 1.13 g, so pl. .
Example 5. Ixg 17o.-butyryloxy-21-chloro-11K-hydroxy-1, 4,8-pregnatriene-3, 20-dione is oxidized anoshogically to Example 4. 8.5 g 17c-butyryloxy-21-chloro-1 , 4.8-pregnatrien-3, 11, 20-trion.
Example 6
A. Analogously to example 16 g 9 (X-chloro-11p-fluoro-17c, 21-dioxy-1, 4-pregnadien-3, 20-dione is reacted with orthobenzoic acid triethyl ester with the formation of 11.1 g -9c.-chloro-1 ifi-FTOR-21-OXI-1, 4-pregnadien-3, 20-dione.
权利要求:
Claims (1)
[1]
1. Djerassi a. Steroid Reactions n-y, 1970, p. 251. R is an acyloxy group such as an acetoxy, propionyloxy, butyryl OXI, benzoyloxy group, characterized in that it is from a corticoid of the general formula.
类似技术:
公开号 | 公开日 | 专利标题
US4377575A|1983-03-22|Corticoid-17-| and process for their manufacture
US2301811A|1942-11-10|2-keto-levo-gulonic acid and process for the manufacture of same
SU730311A3|1980-04-25|Method of preparing corticoids
US3240777A|1966-03-15|Steroid 16alpha-glucuronide of the antiinflammatory pregnane series
SU751327A3|1980-07-23|Method of preparing 9-chloroprednizolone derivatives
US2180095A|1939-11-14|Valuable degradation products of sterols and a method of producing the same
US2728783A|1955-12-27|Process of preparing delta9-3,20-diketo-17alpha-hydroxy-21-acetoxy-pregnene
US3248408A|1966-04-26|Purification of steroid phosphates
KR870001937B1|1987-10-22|Process for preparing|-7-substituted steroid derivatives
US3639392A|1972-02-01|Cardioactive oxido-bufatrienolides
US2813882A|1957-11-19|delta-3, 20-diketo-17-hydroxy-11, 21-bis oxygenated-pregnadiene compounds and processes of preparing the same
US3002010A|1961-09-26|Acylated steroids and method of preparing the same
US4031080A|1977-06-21|16-Alpha-methyl-17 alpha-bromo-1,4-pregnadiene-21-ol-3,20-dione-derivatives
US2705232A|1955-03-29|Ternorcholanylthiazoles
US2953581A|1960-09-20|3-oxygenated-20-keto-21-fluoro-pregnanes
US4585591A|1986-04-29|17β-ethynylsteroids and process for preparing same
US4145357A|1979-03-20|Steroid derivatives and process for preparing the same
US3152119A|1964-10-06|16-substituted-3, 20-diketo pregnenes and esters thereof
US3108125A|1963-10-22|3alpha-amino-20-bis |-pregnanes and process therefor
US4155917A|1979-05-22|Process for preparing D-homo oxasteroids
CA1040191A|1978-10-10|Corticold hormones
US2901397A|1959-08-25|11-oxygenated 9alpha-21-difluoro-1,4 pregnadiene steroidal compositions
US3484476A|1969-12-16|A-nor steroids
US2873284A|1959-02-10|N, n-dialkyl acylamide solvate of 1, 4-pregnadiene-17alpha, 21-diol-3, 11, 20-trione-21-acylate and process of preparing such
SU466654A3|1975-04-05|The method of obtaining 15, 16 methylene steroids
同族专利:
公开号 | 公开日
PL110367B1|1980-07-31|
GB1594371A|1981-07-30|
PL201162A1|1979-01-29|
DE2645104A1|1978-04-06|
DD132438A5|1978-09-27|
IL53031D0|1977-11-30|
IE45781L|1978-04-04|
FI58644C|1981-03-10|
FR2366312B1|1980-02-01|
DK438377A|1978-04-05|
CH634083A5|1983-01-14|
PL111825B1|1980-09-30|
JPS6126554B2|1986-06-20|
SE7711038L|1978-04-05|
GR65016B|1980-06-13|
AU2915477A|1979-04-05|
NO773361L|1978-04-05|
BE859350A|1978-04-04|
ZA775915B|1978-05-30|
ES462888A1|1978-06-01|
PT67110A|1977-11-01|
BG28718A4|1980-06-16|
IL53031A|1981-06-29|
CA1099255A|1981-04-14|
ATA703477A|1980-01-15|
CS199510B2|1980-07-31|
CH634084A5|1983-01-14|
LU78210A1|1978-01-23|
NL7710868A|1978-04-06|
PT67110B|1979-03-14|
CH634082A5|1983-01-14|
BG28264A3|1980-03-25|
BG28717A4|1980-06-16|
FR2366312A1|1978-04-28|
DE2645104C2|1986-04-24|
RO73519A|1981-06-22|
CH634085A5|1983-01-14|
HU177757B|1981-12-28|
IT1087057B|1985-05-31|
US4176126A|1979-11-27|
FI58644B|1980-11-28|
FI772921A|1978-04-05|
IE45781B1|1982-12-01|
AU519212B2|1981-11-19|
NZ185296A|1980-04-28|
JPS5359655A|1978-05-29|
SE431757B|1984-02-27|
AT358201B|1980-08-25|
US4243664A|1981-01-06|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题

US2808415A|1955-01-25|1957-10-01|Merck & Co Inc|Delta4, 8-3, 20-diketo-11, 17-dihydroxy-21-oxygenated-pregnadienes and processes of preparing the same|
US2813882A|1955-01-25|1957-11-19|Merck & Co Inc|delta-3, 20-diketo-17-hydroxy-11, 21-bis oxygenated-pregnadiene compounds and processes of preparing the same|
FR3821M|1963-05-10|Glaxo Lab Ltd|Anti-inflammatory drug based on steroid 17,21-orthoester.|
FR4548M|1963-06-11|
GB1026160A|1964-04-29|1966-04-14|American Cyanamid Co|Pregnatrienes|
US3813420A|1969-02-05|1974-05-28|American Home Prod|13-polycarbonalkyl-3,11,17,20,21-pentaoxygenated-18-norpregnenes|
GB1440064A|1972-08-11|1976-06-23|Glaxo Lab Ltd|Delta8-9- steroids of the pregnane series|FR2510582B1|1981-07-30|1986-05-30|Sipsy|STEROIDS ESTERIFIED IN POSITION 17 AND THIO-ESTERIFIED IN POSITION 21, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICAMENT|
IL66432D0|1981-08-04|1982-12-31|Plurichemie Anstalt|Process for the preparation of steroidal esters|
DE3243482A1|1982-11-22|1984-05-24|Schering AG, 1000 Berlin und 4709 Bergkamen|NEW 6METHYL CORTICOIDS, THEIR PRODUCTION AND USE|
DE3248435A1|1982-12-23|1984-06-28|Schering AG, 1000 Berlin und 4709 Bergkamen|NEW 6METHYLPREDNISOLONE DERIVATIVES THEIR PRODUCTION AND USE|
US4512986A|1983-07-26|1985-04-23|Research Triangle Institute|Progrestationally active steroids|
JPH07116222B2|1989-10-26|1995-12-13|エスエス製薬株式会社|Process for producing 21-desoxyprednisolone-17-ester|
DE4333920A1|1993-10-05|1995-04-13|Hoechst Ag|Corticoid-17,21-dicarboxylic acid esters and corticosteroid-17-carboxylic acid ester-21-carbonic acid esters, processes for their preparation and medicaments containing them|
DE4433374A1|1994-09-20|1996-03-21|Hoechst Ag|17-deoxi-corticosteroid-21- / O / -carboxylic acid ester, process for their preparation and medicaments containing them|
法律状态:
优先权:
申请号 | 申请日 | 专利标题
DE2645104A|DE2645104C2|1976-10-04|1976-10-04|11β-Hydroxy-1,4,8-pregnatriene-3,20-dione derivatives and processes for their preparation|
[返回顶部]